116 participants
Gene-guided N-acetyl Cysteine for Prophylaxis of Anti-tuberculous Drug- Induced Hepatitis
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-07-03
- Start Date:
- 2024-03-12
- Completion:
- 2024-09-18
Conditions
- Tuberculosis (TB)
- Isoniazid Toxicity
- Rifampicin Toxicity
- Pyrazinamide Adverse Reaction
- Ethambutol Toxicity
- NAT2 Slow Acetylator Status
- NAT2 Rapid Acetylator Status
- NAT2 Polymorphism
- N-Acetylcysteine
Interventions
- DRUG
No Results Yet